These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18000177)

  • 21. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Race/ethnicity in medical charts and administrative databases of patients served by community health centers.
    Maizlish N; Herrera L
    Ethn Dis; 2006; 16(2):483-7. PubMed ID: 17682252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care expenditure burdens among adults with diabetes in 2001.
    Bernard DM; Banthin JS; Encinosa WE
    Med Care; 2006 Mar; 44(3):210-5. PubMed ID: 16501391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
    Rathmann W; Haastert B; Icks A; Giani G
    Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
    Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
    J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economics of diabetes mellitus.
    Krein SL; Funnell MM; Piette JD
    Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
    Piette JD; Heisler M; Horne R; Caleb Alexander G
    Soc Sci Med; 2006 Feb; 62(4):846-57. PubMed ID: 16095789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription drug co-payments and cost-related medication underuse.
    Wagner TH; Heisler M; Piette JD
    Health Econ Policy Law; 2008 Jan; 3(Pt 1):51-67. PubMed ID: 18634632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing patient drug acquisition costs can lower diabetes health claims.
    Mahoney JJ
    Am J Manag Care; 2005 Aug; 11(5 Suppl):S170-6. PubMed ID: 16111439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study.
    Brown AF; Gregg EW; Stevens MR; Karter AJ; Weinberger M; Safford MM; Gary TL; Caputo DA; Waitzfelder B; Kim C; Beckles GL
    Diabetes Care; 2005 Dec; 28(12):2864-70. PubMed ID: 16306546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-related medication underuse: prevalence among hospitalized managed care patients.
    Choudhry NK; Saya UY; Shrank WH; Greenberg JO; Melia C; Bilodeau A; Kadehjian EK; Dolan ML; Dudley JC; Kachalia A
    J Hosp Med; 2012 Feb; 7(2):104-9. PubMed ID: 21972200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treat or eat: food insecurity, cost-related medication underuse, and unmet needs.
    Berkowitz SA; Seligman HK; Choudhry NK
    Am J Med; 2014 Apr; 127(4):303-310.e3. PubMed ID: 24440543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in pharmaceutical treatment of diabetes and family financial burdens.
    Sarpong EM; Bernard DM; Miller GE
    Med Care Res Rev; 2012 Aug; 69(4):474-91. PubMed ID: 22513449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative review of studies of diabetes preventive care among minority patients in the United States, 1993-2003.
    Kirk JK; Bell RA; Bertoni AG; Arcury TA; Quandt SA; Goff DC; Narayan KM
    Am J Manag Care; 2005 Jun; 11(6):349-60. PubMed ID: 15974554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic burden of pervasive developmental disorders in a privately insured population.
    Flanders SC; Engelhart L; Whitworth J; Hussein MA; Vanderpoel DR; Sandman T
    Manag Care Interface; 2006 Aug; 19(8):39-45. PubMed ID: 16933527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.